Scarica l'app Stockscreener
3.465
0.72%
-0.025
Dopo l'orario di chiusura:
3.55
0.085
+2.45%
Precedente Chiudi:
$3.49
Aprire:
$3.46
Volume 24 ore:
1.07M
Relative Volume:
1.31
Capitalizzazione di mercato:
$251.43M
Reddito:
$69.23M
Utile/perdita netta:
$-33.10M
Rapporto P/E:
-2.9364
EPS:
-1.18
Flusso di cassa netto:
$-39.26M
1 W Prestazione:
-2.12%
1M Prestazione:
-11.38%
6M Prestazione:
+115.22%
1 anno Prestazione:
+98.00%
Intervallo 1D:
$3.11
$3.49
Intervallo di 1 settimana:
$3.11
$3.61
Portata 52W:
$0.52
$5.92
Neuronetics Inc Stock (STIM) Company Profile
Nome
Neuronetics Inc
Settore
Industria
Telefono
877-600-7555
Indirizzo
3222 PHOENIXVILLE PIKE, MALVERN, PA
Confronta STIM con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
3.465 | 251.43M | 69.23M | -33.10M | -39.26M | -1.18 |
|
ABT
Abbott Laboratories
|
136.26 | 233.36B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
104.78 | 147.06B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
396.74 | 145.64B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.75 | 112.76B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
77.18 | 44.46B | 5.54B | 4.18B | 623.10M | 7.00 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-08-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-10-13 | Downgrade | BTIG Research | Buy → Neutral |
| 2021-10-13 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2021-01-22 | Aggiornamento | William Blair | Mkt Perform → Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2018-07-24 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Neuronetics Inc Borsa (STIM) Ultime notizie
Neuronetics to join Russell 3000 and Russell 2000 indexes - MSN
Neuronetics Announces Clinical Presence At The 2025 Clinical TMS Society Annual Meeting And Progress In Greenbrook's Personalized Care Trial Program - MarketScreener
Neuronetics (STIM) Showcases Innovations in Mental Health Care | - GuruFocus
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS - GuruFocus
Neuronetics (STIM) Showcases Innovations in Mental Health Care | STIM Stock News - GuruFocus
Neuronetics to Present New Research on TMS Therapy at 13th Annual Clinical TMS Society Meeting - Nasdaq
Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook's Personalized Care Trial Program - The Manila Times
NeuroStar's Groundbreaking Study Shows How Its Depression Treatment Compares to Rival Brainsway: Key Findings - Stock Titan
Neuronetics to Join Russell 3000 and Russell 2000 Indexes, Boosting Institutional Visibility - MSN
Neuronetics set to join Russell indexes in June By Investing.com - Investing.com South Africa
Neuronetics set to join Russell indexes in June - Investing.com India
Neuronetics (STIM) to Join Russell 3000 and Russell 2000 Indexes - GuruFocus
Neuronetics Set To Join Russell 2000® And Russell 3000® Indexes - marketscreener.com
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes - GuruFocus
Neuronetics Set to Join Russell 2000® and Russell 3000® Indexes | STIM Stock News - GuruFocus
Neuronetics, Inc. to Join Russell 3000® and Russell 2000® Indexes Effective June 30, 2025 - Nasdaq
Major Milestone: Neuronetics Joins Russell 2000 and 3000 Indexes, Tapping Into $10.6T Benchmark Market - Stock Titan
Transcranial Magnetic Stimulator Market Future Business - openPR.com
Neuronetics reports annual meeting results By Investing.com - Investing.com Canada
Neuronetics reports annual meeting results - Investing.com Australia
Neuronetics Holds Annual Meeting, Elects Directors - TipRanks
Transcranial Magnetic Stimulators (TMS) Market to Set - openPR.com
Neuronetics' SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com UK
Neuronetics’ SWOT analysis: stock outlook brightens post-merger By Investing.com - Investing.com Canada
Neuronetics’ SWOT analysis: stock outlook brightens post-merger - Investing.com
Neuronetics Posts Strong Revenue Growth in Q1 2025 - MSN
Insider Sell: Stephen Furlong Sells 200,000 Shares of Neuronetics Inc (STIM) - GuruFocus
Why We Think Neuronetics, Inc.'s (NASDAQ:STIM) CEO Compensation Is Not Excessive At All - simplywall.st
Neuronetics (STIM) Introduces Annual TMS Therapy Awareness Day | - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awaren - GuruFocus
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month - The Manila Times
Neuronetics Announces Inducement Awards for New Team Members - MSN
Q2 Earnings Forecast for Neuronetics Issued By William Blair - Defense World
Neuronetics, Inc. (NASDAQ:STIM) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.83 - Yahoo
Neuronetics, Inc. (NASDAQ:STIM) Just Reported And Analysts Have Been Lifting Their Price Targets - simplywall.st
Neuronetics, Inc. (NASDAQ:STIM) Q1 2025 Earnings Call Transcript - Insider Monkey
Earnings call transcript: Neuronetics Q1 2025 misses EPS, stock drops 22% - Investing.com Nigeria
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges - Yahoo Finance
Neuronetics Inc (STIM) Q1 2025 Earnings Call Highlights: Revenue Surge Amidst Margin Challenges By GuruFocus - Investing.com Canada
Neuronetics Reports Strong Q1 2025 Growth - TipRanks
Neuronetics: Q1 Earnings Snapshot - CTPost
Neuronetics Q1 2025 Earnings Call Transcript - MarketBeat
Neuronetics, Inc. Provides Earnings Guidance for the Second Quarter of 2025 - marketscreener.com
Neuronetics Q1 2025 slides: Combined entity targets profitability by Q3 amid 84% revenue growth - Investing.com Canada
Neuronetics Inc Azioni (STIM) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Neuronetics Inc Azioni (STIM) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Furlong Stephen | EVP, CFO and Treasurer |
May 13 '25 |
Sale |
4.16 |
6,540 |
27,206 |
410,053 |
4.52%
0.92%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):